A detailed history of High Vista Strategies LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, High Vista Strategies LLC holds 65,027 shares of OCUL stock, worth $541,674. This represents 0.22% of its overall portfolio holdings.

Number of Shares
65,027
Previous 61,859 5.12%
Holding current value
$541,674
Previous $423,000 33.57%
% of portfolio
0.22%
Previous 0.17%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.45 - $9.23 $20,433 - $29,240
3,168 Added 5.12%
65,027 $565,000
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $259,807 - $537,554
61,859 New
61,859 $423,000
Q1 2022

May 16, 2022

SELL
$4.83 - $7.35 $284,800 - $433,392
-58,965 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$6.16 - $12.07 $62,197 - $121,870
-10,097 Reduced 14.62%
58,965 $411,000
Q3 2021

Nov 15, 2021

BUY
$9.7 - $14.34 $72,003 - $106,445
7,423 Added 12.04%
69,062 $691,000
Q2 2021

Aug 16, 2021

BUY
$13.43 - $19.16 $827,811 - $1.18 Million
61,639 New
61,639 $875,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $641M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.